BF-114

N/A

Report date: 2024/04/09 17:56:34
NME

Base Information

Drug NameBF-114
Drug Alias NameBF-114
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionSpectrin beta chain, non-erythrocytic 1 inhibitorsRNA interference
TargetsSpectrin beta chain, non-erythrocytic 1
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe George Washington University
China Registration ClassN/A

Develop Information

Active CompaniesBullFrog AI Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A